DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing
Engelberts, Patrick J., Hiemstra, Ida H., de Jong, Bart, Schuurhuis, Danita H., Meesters, Joyce, Beltran Hernandez, Irati, Oostindie, Simone C., Neijssen, Joost, van den Brink, Edward N., Horbach, G.Volume:
52
Language:
english
Journal:
EBioMedicine
DOI:
10.1016/j.ebiom.2019.102625
Date:
February, 2020
File:
PDF, 3.07 MB
english, 2020